Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

SYNTAX creates common ground for coronary risk assessment

Sep. 3, 2010

Guidelines praise new tech, but give stents short shrift

Sep. 2, 2010

GE unit sees $1 billion opportunity in healthcare reform market

Sep. 1, 2010

German IVD for cervical cancer aims to disrupt U.S. market

Aug. 23, 2010

Report from Europe: GE unit sees $1B opportunity in healthcare reform market

Aug. 4, 2010

Tale of two citations:Value of med-tech depends on agenda

Aug. 1, 2010

Report from Europe: Micro-optimism detected among nano manufacturers

July 22, 2010

Report from Europe: Tale of two citations: Value of med-tech depends on agenda

July 21, 2010

Report from Europe: IPO for Carmat's artificial heart exceeds expectations

July 9, 2010

Compelling registry results help to clinch clinical case for TAVI

July 1, 2010

View All Articles by John Brosky

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...